Rigel Pharmaceuticals Inc (NASDAQ:RIGL)
| 1.26 Delayed Data As of Mar 24 |  -0.015 / -1.17%Today’s Change | 0.64 Today|||52-Week Range 3.29 | -15.67% Year-to-Date |
Latest RIGL News | Press Releases
No recent news for Rigel Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.28 |
| Today’s open | 1.28 |
| Day’s range | 1.24 - 1.29 |
| Volume | 60,842 |
| Average volume (3 months) | 4,088,739 |
| Market cap | $256.1M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -223.22% |
| Earnings growth (this year) | +16.26% |
| Earnings growth (next 5 years) | +42.00% |
| Revenue growth (last year) | -19.43% |
| P/E ratio | NM |
| Price/Sales | 2.15 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SELBSelecta Biosciences ... | -0.04 | -3.10% |
| XOMAXOMA Corp | +1.74 | +8.58% |
| PGENPrecigen Inc | +0.03 | +2.93% |
| KZRKezar Life Sciences ... | +0.00 | +0.15% |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | May 2, 2023 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $120.2M |
| Annual profit (last year) | -$58.6M |
| Net profit margin | -48.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
